LSD vs Psilocybin

Comparing LSD vs psilocybin comes down to duration, legal access, and how far along each one is in medical research. Both are classic psychedelics that act on the same brain receptor and can produce deep emotional experiences. But they differ in how long they last, where you can legally access them, and how much trial data exists. This guide compares them side by side so you can understand the real differences.

Quick answer: LSD vs psilocybin

Psilocybin is the more clinically advanced and more legally accessible of the two. Its shorter 4-to-6-hour session fits a therapy setting, and it has strong late-stage depression data plus regulated access in Oregon and Colorado. LSD lasts much longer, has less depression trial data, and has no regulated legal path anywhere in the US, though it is now in Phase 3 trials for anxiety. For most people weighing a supported experience today, psilocybin is the more practical option.

LSD vs psilocybin: side-by-side comparison

How LSD and psilocybin work

LSD and psilocybin act on the same main target in the brain. Both are agonists at the 5-HT_2A serotonin receptor.¹ This shared mechanism is why their core effects feel so similar: shifting perception, looser thinking, and often strong emotional or mystical states. Our psilocybin guide and LSD guide cover the science of each in depth.

There are small differences under the hood. LSD also touches dopamine receptors and binds its target very tightly, which helps explain its long duration. Psilocybin is a "prodrug," meaning the body converts it into psilocin, the active compound. These molecular differences shape how long each lasts and how the experience unfolds, even though the felt effects overlap a lot.

Duration and the experience

Duration is the difference most people notice first. A psilocybin experience usually lasts 4 to 6 hours. An LSD experience typically runs 8 to 11 hours, filling most of a waking day.² That gap has real consequences for supported sessions.

A direct double-blind study that compared the two in healthy volunteers found that, at the doses used, their subjective effects were very similar in quality.² The main difference was time: LSD simply lasted longer. This is a big reason psilocybin has moved faster through clinical research. A shorter session fits inside a normal therapy day and costs less to staff with a trained guide.

Which feels more intense?

At comparable doses, neither is reliably "more intense" than the other in quality. LSD's longer arc can make it feel more demanding simply because it lasts so long. Psilocybin's shorter window can feel more contained. Set, setting, dose, and the person matter far more than the specific molecule when it comes to how challenging a session feels.

What the evidence shows

Psilocybin for depression

Psilocybin has the deeper clinical record for depression. In 2025, COMPASS Pathways reported that both Phase 3 trials of its COMP360 psilocybin hit their primary endpoints for treatment-resistant depression.³ Broader reviews find large effect sizes for psilocybin in major depression, with benefits lasting for some patients out to six months.⁴ It is not yet a prescription you can fill, but its data is strong.

LSD for anxiety

LSD's modern trial program centers on anxiety, not depression. In March 2024, the FDA granted Breakthrough Therapy designation to MM120, an LSD-based drug from MindMed, for generalized anxiety disorder after a positive Phase 2b study.⁵ The company then launched Phase 3 trials, the first-ever Phase 3 studies of LSD for any condition. Depression-specific LSD trials remain far fewer than psilocybin's.

Legal status: the deciding factor for access

Both LSD and psilocybin are Schedule I at the federal level, which means no accepted medical use in the government's eyes and no prescription path.⁶ The practical difference is regulated access. Psilocybin has legal, supervised programs in Oregon (Measure 109) and Colorado (Proposition 122). LSD has no such program anywhere in the US.

So if you want a legal, supervised psychedelic experience today, psilocybin in Oregon or Colorado is the only option between these two, outside of a clinical trial. To see how your state treats each drug, check our guide on what psychedelics are legal in the US. You can also look up open studies with our clinical trial finder.

What about microdosing?

People microdose both LSD and psilocybin, but the evidence is thin. Most well-controlled studies have not shown clear benefits over placebo. Microdosing either substance outside a regulated program is also illegal. Treat microdosing claims with healthy caution, and never assume small doses are risk-free.

The verdict: LSD vs psilocybin — which is right for you?

Consider psilocybin if you want the option with legal regulated access, a shorter session that fits a therapy setting, and the strongest depression trial data. It is the more clinically advanced and more accessible of the two today.

Consider LSD if you are following anxiety research specifically or would join a clinical trial, and you are comfortable with a much longer session. Its Breakthrough Therapy work targets generalized anxiety, but it has no regulated legal path outside of trials right now.

Curious how these compare to other options for your goals? Take our which psychedelic quiz for a personalized starting point, or read ketamine vs psilocybin for the access-versus-experience trade-off.